About Mylin Biotech India Private Limited
Data last updated:
Mylin Biotech India Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 10 December 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U73100KA2012PTC067115. Its GSTIN is 29AAICM3171B1ZM (Karnataka).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹3.45 Lakh. It is led by directors including Kavitha Prabakaran and Ramasamy Ramajayam Pillai.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at #254/1 – 9 11th Main Road 3rd Phase Peenya, Bangalore Karnataka – 560058, Karnataka, India – 560058.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.1 Cr, a growth of 64% compared to the previous year. For the same year it recorded a net profit of ₹1.06 Cr (net margin 13.1%) and EBITDA of ₹1.81 Cr (EBITDA margin 22.4%). Revenue has grown at a compounded annual rate (CAGR) of 62% over three years and 34% over five years.
The company has about 15 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Mylin Biotech. As per MCA filings, the company has open charges of ₹3.58 Cr and satisfied charges of ₹35 Lakh on record. The company has 1 deal on record (1 rights issue); the latest was in May 2022. Its 10 peer companies in the Healthcare industry (Pharma Retail and Distribution, Preventive Healthcare Services) are compared by revenue, 5 larger and 5 smaller; the largest is Nav Jeevan Jyoti Hospital Private Limited with revenue of ₹8.13 Cr. The company has 2 MSME Form 1 returns on record for the period ending Sep 2019, listing 3 overdue payments to 1 micro and small supplier.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mylinbiotech.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address#254/1 – 9 11th Main Road 3rd Phase Peenya, Bangalore Karnataka – 560058, Karnataka, India – 560058
- IndustryHealthcare, Preventive Health Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Mylin Biotech India Private Limited
The main business activity of Mylin Biotech India is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Mylin Biotech India Private Limited FY 2025 filings available
Mylin Biotech India Private Limited reported revenue of ₹8.1 Cr (up 64% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Mylin Biotech India Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 34% over five years, including 64% growth in the latest year. EBITDA rose 644% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Mylin Biotech India Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.81 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.06 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Mylin Biotech India Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 22.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 13.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Mylin Biotech India are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Mylin Biotech India Private Limited
Mylin Biotech India Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Pharma Retail and Distribution, Preventive Healthcare Services). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nav Jeevan Jyoti Hospital Private Limited | ₹8.13 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Padrauna, Uttar Pradesh, India |
| Aastha Lok Hospital Private Limited | ₹8.12 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Patna, Bihar, India |
| Arthrogen Medical Private Limited | ₹8.11 Cr (FY 2025) | •••• | •••• | 247.0% | •••• | Indore, Madhya Pradesh, India |
| Shreevedanta Healthcare Private Limited | ₹8.11 Cr (FY 2022) | •••• | •••• | 187.0% | •••• | Yellareddy Guda, Hyderabad, Telangana, India |
| Bone and Joint Clinic Private Limited | ₹8.1 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Chennai, Tamil Nadu, India |
| Mylin Biotech India Private Limited this company | ₹8.1 Cr (FY 2025) | •••• | •••• | 64.0% | •••• | Bangalore, Karnataka, India |
| Jindal Medicines Pvt Ltd | ₹8.1 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Jalandhar, Punjab, India |
| Family Farmace Private Limited | ₹8.1 Cr (FY 2019) | •••• | •••• | -1.0% | •••• | New Delhi, Delhi, India |
| Reichindia Bio - Applications Limited | ₹8.1 Cr (FY 2024) | •••• | •••• | 4.0% | •••• | Hyderabad, Telangana, India |
| Westmed Healthcare Private Limited | ₹8.09 Cr (FY 2025) | •••• | •••• | 47.0% | •••• | Puducherry, India |
| Matrix Biomedics Private Limited | ₹8.09 Cr (FY 2025) | •••• | •••• | 28.0% | •••• | Pune, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Mylin Biotech India by revenue in the Healthcare industry (Pharma Retail and Distribution, Preventive Healthcare Services), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Mylin Biotech India Private Limited
Mylin Biotech India Private Limited is audited by AGARWAL JAIN S AND CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| AGARWAL JAIN S AND CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Mylin Biotech India Private Limited
Mylin Biotech India has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kavitha Prabakaran | Director | 10 Dec 2012 | 13 Years 9 Months | Current |
| Ramasamy Ramajayam Pillai | Director | 10 Dec 2012 | 13 Years 9 Months | Current |
| Pandurangan Prabhakran | Director | 09 May 2022 | 4 Years 4 Months | Current |
Ownership and Shareholding of Mylin Biotech India Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Mylin Biotech India Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Apr 2022 | State Bank of India | ₹3.26 Cr | Open |
| 09 Dec 2020 | Hdfc Bank Limited | ₹32 Lakh | Open |
| 20 May 2021 | Hdfc Bank Limited | ₹35 Lakh | Satisfied |
Total charge records: 3 View all charges
Deals & Funding of Mylin Biotech India Private Limited
Mylin Biotech India Private Limited has 1 deal on record (1 rights issue); the latest was in May 2022.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2022 | Rights issue | ₹33 Lakh | Investors: an individual |
Full deal history
All 1 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
MSME Payment Delays by Mylin Biotech India Private Limited
Mylin Biotech India Private Limited has 2 MSME Form 1 returns on record for the period ending Sep 2019, listing 3 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Mystical Biotech Private Limited | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 2 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Mylin Biotech India Private Limited
Mylin Biotech India operates one associated brand: Mylin Biotech. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Biotech company focusing on gut-centric healthcare solutions and manufacturing. | mylinbiotech.com |
Employees and EPFO Compliance at Mylin Biotech India Private Limited
Mylin Biotech India Private Limited has a workforce of 15 employees as of Apr 06, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Mylin Biotech India Private Limited
Mylin Biotech India Private Limited has 4 board changes on record since 2012: 3 appointments and 1 cessation. The latest: Pandurangan Prabhakran ceased to be Additional Director on 30 Sep 2022.
Credit Ratings, Litigation & Regulatory Alerts for Mylin Biotech India Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Mylin Biotech India Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Mylin Biotech India Private Limited
Mylin Biotech India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAICM3171B1ZM | Karnataka | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Mylin Biotech India Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mylin Biotech India Private Limited
Mylin Biotech India is an active private limited company based in Bangalore, Karnataka, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 10 December 2012 (14+ years old) and is registered under CIN U73100KA2012PTC067115.
Mylin Biotech India reported revenue of ₹8.1 Cr for FY 2025 (up 64% YoY).
Mylin Biotech India has 3 current directors:
- Kavitha Prabakaran - Director
- Ramasamy Ramajayam Pillai - Director
- Pandurangan Prabhakran - Director
Mylin Biotech India reported a net profit of ₹1.06 Cr (net margin 13.1%) and EBITDA of ₹1.81 Cr (EBITDA margin 22.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Mylin Biotech India is 62% over three years and 34% over five years. In the latest year (FY 2025) revenue rose 64%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Mylin Biotech India is 29AAICM3171B1ZM, registered in Karnataka.
The CIN (Corporate Identification Number) of Mylin Biotech India is U73100KA2012PTC067115. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mylin Biotech India was incorporated on 10 December 2012, making it 14+ years old. It is registered with the Registrar of Companies, Bangalore.
Mylin Biotech India has 1 deal on record (1 rights issue); the latest was in May 2022.
The peers of Mylin Biotech India by revenue are Nav Jeevan Jyoti Hospital Private Limited, Aastha Lok Hospital Private Limited, Arthrogen Medical Private Limited, Shreevedanta Healthcare Private Limited, Bone and Joint Clinic Private Limited and 5 more, all in the Healthcare industry (Pharma Retail and Distribution, Preventive Healthcare Services).
Pandurangan Prabhakran ceased to be Additional Director on 30 Sep 2022. Pandurangan Prabhakran was appointed as Director on 09 May 2022. Kavitha Prabakaran was appointed as Director on 10 Dec 2012. Mylin Biotech India has 4 board changes on record in total.
Mylin Biotech India has 2 MSME Form 1 returns on record for the period ending Sep 2019, listing 3 overdue payments to 1 micro and small supplier. The latest return was filed on 29 Oct 2019.